The WHO just cut the Bundibugyo case count way down — so the real question isn't whether that sounds good, it's whether we trust how they got there. I'm Daniel, and on today's Ebola Watch: the official number got smaller, South Sudan just landed on CDC's post-travel screening list, and European and African regulators are finally in the same room talking treatments. Let's see which of that is actually good news. I'm Cassidy. The institutions are moving now — WHO revised the count, MSF is on the ground as of June 3rd, and EMA plus the African Medicines Agency held a joint coordination call. So today we're not rehashing the problem. We're grading the answers. And Tedros did a fifty-eight minute press briefing yesterday, so yeah, we have plenty of specifics to drag into the light. Here's Who:
In DRC, 344 cases have been confirmed, including 60 deaths, in 24 health zones across three different provinces: Ituri, North Kivu and South Kivu The number of suspected cases has now been reduced to 116 from over 1000 last week, as we work through the backlog, either confirming them or ruling them out.
Tedros was in Ituri yesterday — that's the epicenter — and the numbers he brought back to Geneva need to be separated carefully: 344 confirmed cases in DRC, 60 deaths, 15 confirmed in Uganda. That's the confirmed column. The suspected count dropped from over a thousand last week to 116, which is the reclassification piece I flagged — but he described it as working through a backlog, not as a lab-result sweep, so the question is whether this is active confirmation or just administrative pruning. So CIDRAP says WHO drastically downsized the case count, and Tedros says they're working through the backlog. Those are not the same story. One sounds like the original number was bloated by reporting; the other sounds like the process is still catching up. If you're traveling through Ituri, that difference matters. They're not mutually exclusive — but the mechanism is what tells you how much faith to put in the next number. If this is ongoing lab confirmation, that 116 suspected figure can still move either way. And that Uganda case that went through the UAE — that's a confirmed case touching an international hub. It came up in a fifty-eight minute briefing, and I don't want it getting buried under the DRC math. From Stephanie Soucheray at CIDRAP:
Another 116 cases are suspected. In Uganda, the new case count is 11 confirmed cases, one confirmed death, one probable case, and one probable death. But rather than signaling good news, relief organizations caution that the mixed messaging is part of a broader, chaotic picture of an outbreak that may have been simmering for months and could take several more months to contain.
The revision is official now, and the sourcing is clear: WHO and CDC have moved the combined DRC-Uganda case count from nearly a thousand down to 321 confirmed cases — plus 116 suspected, which is still a different category. That distinction is exactly why the old number was misleading. What matters now is the revision mechanism: was this a lab-based reclassification of individual cases, or a methodological recount of how suspected cases were being logged? Those have different implications for whether we trust the next number. I want to sit with how big that swing is for a second — nearly a thousand down to 321 is not a rounding error, that's a wholesale reset of what we thought we knew. And then you’ve got the International Medical Corps physician in Goma saying 20% of cases are healthcare workers and this could run beyond six months. So the official count got smaller, and the field picture got uglier, on the same day. That's the line from Dr. Sebushishe that I'd keep coming back to: the outbreak is outpacing the current response. That's not a Geneva communique — that's somebody in Goma telling CBS the response is playing catch-up. The revised number doesn't change that; if anything, a cleaner confirmed count makes it harder to shrug the chaos off as a data artifact. And Uganda is at 11 confirmed cases on its side, with one confirmed death — still small numbers, but South Sudan just got added to the CDC post-travel screening list alongside DRC and Uganda, so the perimeter is still widening even as the case count came down. From CDC:
CDC is monitoring an outbreak of Ebola disease in areas of the Democratic Republic of the Congo (DRC) and Uganda. At this time, areas of concern include all of DRC and Kampala in Uganda. CDC is assessing travelers into the United States who have been in DRC or Uganda, as well as neighboring South Sudan, for symptoms of and possible exposure to Ebola.
So the CDC post-travel page — dated May 28 and still active today — now explicitly puts South Sudan on the list with DRC and Uganda as a country that triggers active traveler screening into the United States. That's a geographic expansion, and if you have anything touching Juba or a cross-border route into either country, that's a real itinerary question right now. Worth separating the categories here: CDC says all of DRC and Kampala specifically in Uganda are areas of concern, which means daily temperature checks for 21 days. South Sudan triggers screening, but it's not yet an area of concern — and that is a real operational difference. I'd rather listeners know exactly which column they're in. And that page held steady through yesterday's WHO revision. The official number dropped, but the screening posture didn't — and if you're trying to figure out what CDC actually thinks is happening here, those two facts belong together. Doctors Without Borders, with Salwa:
MSF teams are often among the first humanitarian responders for one key reason: because we are already there. MSF has been working in DRC since 1977, providing vital healthcare services through conflict, disaster and disease. Right now, we have hundreds of staff responding to the outbreak in eastern DRC.
MSF formally mobilized on June 3rd, and the geography matters here — they're going into Ituri province, the same eastern DRC epicenter where Bloomberg's contact-tracing data showed fewer than four in ten contacts actually being followed up. That's not overlap. That's MSF walking into a surveillance gap. And MSF's own page says over 900 suspected cases and 223 deaths, which doesn't line up with what WHO revised downward yesterday. So right now a field organization and the world's top public health body are working from different case counts. That's real tension, and people should hear it. That's exactly where the confirmed-versus-suspected distinction stops being abstract and starts affecting the response on the ground. MSF is staging against a suspected-case number that WHO just revised, so the methodology question I raised earlier this week isn't academic anymore. Here's European Medicines Agency:
EMA’s Emergency Task Force (ETF) is engaging with the African Medicines Agency (AMA) and its national regulatory authorities (NRAs), leveraging expertise from the WHO-AFRO African Vaccines Regulatory Forum (AVAREF), to discuss possible clinical trial designs and medical countermeasures to be investigated in the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda, caused by the Bundibugyo virus.
The 'no approved anything' thread we’ve been following since Monday just moved. EMA's Emergency Task Force is now formally engaged with the African Medicines Agency and national regulators across the continent — June 3rd, on the record — to discuss clinical trial designs and medical countermeasures for Bundibugyo. That's not just a press release saying work is underway; that's the first named multilateral regulatory body at the table. One thing to keep in view: EMA says this is the first public health emergency where they've collaborated with the AMA since the AMA became operational. So the coordination structure itself is being stress-tested in real time against a live outbreak, with a virus strain that still doesn't have approved countermeasures. 'Joining forces' is not the same thing as agreed trial protocols, and we don't yet know which one we're looking at. Okay, but I need specifics — what candidates are actually on the table? Because 'discuss possible clinical trial designs' is a starting line, not a finish line, and we've been at no approved treatments for Bundibugyo all week. Is there anything in that room that could realistically reach emergency authorization before the outbreak peaks? If you follow Ebola Watch for clear outbreak updates, try Hantavirus Watch: daily updates on the 2026 outbreak, including the MV Hondius Andes-virus cluster, CDC and WHO response, contact tracing, and traveler risk. Find it wherever you listen to podcasts.
You'll find links to all of today's stories in the show notes, so if one caught your attention, you can read more there. Thanks for listening this Thursday. That's Ebola Watch for today. This is a Lantern Podcast.